Disposable Syringes Market Size, Share, 2032
Disposable Syringes Market Size and Forecast (2025 - 2032), By Product Type (Conventional Syringes, Safety Syringes, Prefilled Syringes), By Application (Immunization Injections, Therapeutic Injections), By End User (Hospitals, Clinics, Blood Collection Centers, Others), and Geography.
Market Overview:
“The Disposable Syringes Market is expected to reach a high CAGR of 6.1% over the Forecast Period 2025-2032, reaching USD 16.2 billion by 2032.”
Asia-Pacific dominates the market, accounting for YY% of the global share. The market is driven by increasing healthcare expenditure, rising prevalence of chronic diseases, and growing awareness about infection control.
Disposable Syringes Market Dynamics:
Market Trend: Shift towards safety-engineered syringes to prevent needlestick injuries and reduce healthcare-associated infections.
The disposable syringe market is experiencing a considerable shift towards safety-engineered syringes. These modern gadgets include built-in safety features to avoid needlestick injuries and limit the danger of bloodborne pathogen transmission. According to our research analysis, safety syringes can minimise needlestick injuries by up to 80% when compared to traditional syringes. This tendency is further fuelled by severe rules in many countries that require the use of safety equipment in healthcare settings. For example, the European Union's Directive 2010/32/EU requires healthcare facilities to utilise safety-engineered medical devices to protect employees from injury.
Adoption of safety syringes is also pushed by the potential to minimise healthcare expenses connected with needlestick injuries, which are estimated to be $3,000 per occurrence for testing and follow-up. As healthcare workers become more conscious of occupational hazards, demand for safety-engineered syringes is likely to rise, changing the disposable syringe market landscape.
Market Driver: Increasing prevalence of chronic diseases and growing immunization programs worldwide fuel market expansion.
The increased frequency of chronic diseases, combined with expanded immunization efforts, is a major driver of disposable syringe market growth. Chronic illnesses like diabetes, which require regular insulin injections, have experienced a huge increase worldwide. According to the International Diabetes Federation, the number of adults with diabetes has increased from 463 million in 2019 to 537 million in 2021, and this trend is likely to continue. This rising patient population creates a greater demand for disposable syringes for drug administration.
Additionally, worldwide immunisation attempts have gained traction, notably in the aftermath of the COVID-19 epidemic. The World Health Organization's Immunisation Agenda 2030 intends to vaccinate 90% of the world's children against numerous diseases, which increases the demand for disposable syringes. Furthermore, ongoing COVID-19 immunisation efforts have dramatically increased syringe demand, with an expected 16 billion doses administered globally by early 2024, opening up unprecedented market prospects for disposable syringe makers.
Market Restraint: Environmental concerns associated with plastic syringe disposal and potential for counterfeiting pose challenges to market growth.
The environmental impact of disposable plastic syringes poses a significant barrier to business expansion. With billions of syringes used each year, proper disposal of these single-use devices has become a major challenge. According to studies, healthcare facilities in the United States generate over 25 tonnes of plastic trash every day, with disposable medical items such as syringes accounting for a significant fraction of that total. This environmental load has prompted growing scrutiny and demand for more sustainable options.
Some hospitals indicate that implementing complete medical plastic recycling programs can save up to 40% on waste disposal expenses, but such initiatives are not yet widespread. Furthermore, the market confronts threats from counterfeit items, especially in emerging countries. According to the World Health Organisation, up to one out of every ten medical products in low- and middle-income nations is substandard or counterfeit, including disposable syringes. These counterfeit items not only endanger public health, but they also stifle market growth and weaken customer confidence. Addressing environmental and quality control challenges is critical for long-term market growth and improved global healthcare outcomes.
Segment Overview:
Safety syringes dominate the product type segment, accounting for YY% of the market share in 2023.
Safety syringes dominate the disposable syringes industry. This dominance is linked to a growing emphasis on healthcare worker safety and strict rules requiring the use of safety devices in medical environments. Safety syringes, which include features such as retractable needles and protective covers, have demonstrated exceptional success in preventing needlestick injuries. A recent study published in the New England Journal of Medicine found that implementing safety syringes in a large hospital system reduced percutaneous injuries among healthcare workers by 74% over a five-year period.
The long-term cost-effectiveness of safety syringes drives the segment's expansion even further. While initially more expensive than traditional syringes, safety devices greatly lower the expenses of needlestick injuries, such as testing, treatment, and lost productivity. A thorough investigation by the American Journal of Infection Control discovered that switching to safety syringes can result in net savings of up to $160,000 per year for a 350-bed hospital.
Furthermore, technological breakthroughs in safety syringe design have increased user acceptance and patient satisfaction. New generation safety syringes have ergonomic shapes and smoother activation mechanisms, which solve past complaints about ease of use. This has resulted in higher acceptance rates, with some healthcare facilities reporting 98% compliance with safety device use after staff training and education campaigns. As awareness of workplace dangers in healthcare settings grows, combined with stronger regulatory frameworks, the safety syringes industry is expected to rise steadily in the future years.
Regional Outlook:
Asia-Pacific: Leading the global disposable syringes market with a YY% share in 2023.
Asia-Pacific's dominance in the disposable syringe market is due to its vast population base, rising healthcare spending, and increased awareness of safe injection techniques. The region benefits from significant economic growth, rising healthcare infrastructure, and government programs aimed at improving healthcare access.
In February 2024, a major pharmaceutical company in India announced the opening of a new production facility specialized to the manufacture of safety syringes, with an annual capacity of 1.5 billion. This development is projected to greatly increase the region's production capabilities, potentially reshaping the global disposable syringe supply chain.
The disposable syringes market in Asia-Pacific is expected to increase at a CAGR of 7.5% between 2024 and 2031, exceeding the global average. The region contributes to nearly 40% of global immunization programs, creating a significant need for disposable syringes.
In China, the government announced a new regulation in January 2024 that requires the use of safety-engineered syringes in all public hospitals by 2026. This strategy is likely to drive up demand for safety syringes, perhaps tripling the market size in China over the following five years.
Competitive Intelligence:
The disposable syringes market is characterised by fierce rivalry among prominent companies who prioritise product innovation, strategic collaborations, and global expansion. Market players such as Becton, Dickinson and Company (BD), Terumo Corporation, and B. Braun Melsungen AG have considerable market shares due to their strong global presence and diversified product portfolios.
These companies have made significant investments in research and development to create new safety features and improve the user experience. For example, BD's recent introduction of a new generation of prefilled syringes with improved stability for sensitive biologics has boosted its position in the biopharmaceutical industry. Similarly, Terumo's focus on developing breakthrough medication delivery methods has resulted in strategic agreements with pharmaceutical companies, which have helped it extend its market share.
The market has also seen a trend of consolidation, with larger companies purchasing smaller, innovative firms to broaden their product offerings and technological capabilities. For example, in 2023, a major medical device business acquired a specialised safety syringe producer, reshaping the competitive environment in the safety syringes segment.
Emerging businesses, notably from Asia-Pacific, are rapidly challenging existing market leaders by providing low-cost products and focussing on high-growth sectors. To achieve market share, these enterprises rely on local production skills and distribution networks, particularly in developing economies.
Regulations and government activities promoting safe injecting techniques have an additional impact on competitive dynamics. Companies who can swiftly adjust to changing requirements and provide extensive training and support services will likely gain a competitive advantage in the coming years.
Analyst Opinion:
The disposable syringes market is expected to expand rapidly, owing to rising healthcare demands and a greater emphasis on infection prevention. The transition to safety-engineered syringes represents a watershed moment that is likely to change industry norms and increase healthcare worker safety. While traditional syringes continue to have a considerable market share, the fast adoption of safety devices in developed markets and rising awareness in emerging nations point to a transformative period ahead.
The combination of digital technologies and disposable syringes is a promising commercial trend. Smart syringes with dose tracking and patient compliance monitoring capabilities are emerging as a niche market with significant growth potential. This trend is consistent with the larger drive towards linked healthcare equipment and has the potential to transform medication adherence and treatment results.
However, the sector confronts hurdles, particularly in dealing with environmental concerns related to plastic waste. Sustainable expansion will require the development of environmentally friendly products as well as the deployment of efficient recycling processes. Companies who can innovate in this field may have a substantial competitive advantage.
Another area of interest is the increase of prefilled syringe options, particularly for biologics and vaccinations. The convenience and dosage precision of prefilled syringes, together with the rising biopharmaceutical business, provide significant prospects for market competitors.
Major Players:
-
Becton, Dickinson and Company (BD)
-
Terumo Corporation
-
B. Braun Melsungen AG
-
Smiths Medical
-
Nipro Corporation
-
Hindustan Syringes & Medical Devices Ltd.
-
Cardinal Health
-
Retractable Technologies, Inc.
-
Gerresheimer AG
-
Schott AG
Key Developments:
-
July 2023: Becton, Dickinson, and Company introduced a new line of ultra-low waste syringes aimed at increasing the number of doses retrieved from COVID-19 vaccine vials.
-
Terumo Corporation established a strategic agreement with a top pharmaceutical company in October 2023 to create specialised prefilled syringes for a breakthrough biologic medication.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking -- Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies list by Country) (Premium)
5. COMPANY PROFILES
5.1. Becton, Dickinson and Company (BD)
5.2. Terumo Corporation
5.3. B. Braun Melsungen AG
5.4. Smiths Medical
5.5. Nipro Corporation
5.6. Hindustan Syringes & Medical Devices Ltd.
5.7. Cardinal Health
5.8. Retractable Technologies, Inc.
5.9. Gerresheimer AG
5.10. Schott AG
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Shift towards safety-engineered syringes to prevent needlestick injuries
6.1.2. Integration of digital technologies in disposable syringes
6.1.3. Growing demand for prefilled syringes in biopharmaceuticals
6.2. Market Drivers
6.2.1. Increasing prevalence of chronic diseases and growing immunization programs worldwide
6.2.2. Rising focus on infection control and prevention in healthcare settings
6.2.3. Technological advancements in syringe design and materials
6.3. Market Restraints
6.3.1. Environmental concerns associated with plastic syringe disposal
6.3.2. Potential for counterfeiting and quality control issues
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
7.1. Conventional Syringes
7.2. Safety Syringes
7.2.1. Retractable Safety Syringes
7.2.2. Non-Retractable Safety Syringes
7.3. Prefilled Syringes
8. BY APPLICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
8.1. Immunization Injections
8.2. Therapeutic Injections
8.2.1. Insulin Administration
8.2.2. Drug Delivery
8.2.3. Others
9. BY END USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
9.1. Hospitals
9.2. Clinics
9.3. Blood Collection Centers
9.4. Others
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
By Product Type:
-
Conventional Syringes
-
Safety Syringes
-
Prefilled Syringes
By Application:
-
Immunization Injections
-
Therapeutic Injections
By End User:
-
Hospitals
-
Clinics
-
Blood Collection Centers
-
Others
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511